Alkem Laboratories Posts Strong Q2 FY26 - Sees 17% Revenue Growth, 22% Rise in EBITDA
Alkem Laboratories Ltd. reported robust performance for the second quarter ended 30 September 2025. The company recorded revenues of Rs. 40,010 million, up by 17.2 % year-on-year.










